Join Genomind and our panel of experts for a psychiatric case roundtable with a focus on pharmacogenetics. Our panel features Dr. Judith Engelman, MD, Jennifer Reed, PMHNP-BC, and Dr. Rachel Shmuts, DO, PMH-C, and is moderated by members of Genomind’s Medical Affairs team, Dr. Seema Patel, PharmD, BCPP and Dr. Gabriela Williams, PharmD, BCPS, BCPP. Read More
Join Genomind’s Vice President of Medical Affairs, Dr. Daniel Dowd, for a clinical presentation. Dr. Dowd discusses pharmacogenetic considerations that can be applied in the treatment of geriatric and comorbid patients. He also demonstrates how GenMed✓ Pro, Genomind’s precision gene-drug interaction software, can be utilized in the assessment of treatment options for this population.
It takes approx. seven years to diagnose a patient with a rare disease. It doesn’t have to be this way. We are excited to share that our enhanced Whole Exome Sequencing (WES) solution is now out! All WES samples received by our lab starting 1st June will be on this new enhanced CentoXome®. We are Read More
Join Genomind’s Medical Science Liaisons, Dr. Russell Amato and Dr. Tori Hoffman, as they present on the management of generalized anxiety disorder. They will discuss various treatment options and associated evidence, as well as highlight pharmacogenetic considerations in the management of this challenging clinical presentation.
Genomind and guest speaker, Dr. Jeffrey R. Strawn, MD, FAACP, present Beyond One Size Fits All: Using Pharmacogenetics to Improve Antidepressant Efficacy and Tolerability in Children and Adolescents. Dr. Strawn, an Associate Professor of the Department of Pediatrics at the University of Cincinnati, is a psychiatrist specializing in the neurophysiology, neurochemistry and neuroanatomy of anxiety Read More